A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand

Overview

Journal PLoS Negl Trop Dis

Specialties Infectious Diseases
Tropical Medicine

Date 2016 Jan 23

PMID 26797527

Citations 29

Authors

Narong Khuntikeo

Watcharin Loilome

Bandit Thinkhamrop

Nittaya Chamadol

Puangrat Yongvanit

Affiliations

Soon will be listed here.

Citing Articles

Improvement of survival outcomes of cholangiocarcinoma by ultrasonography surveillance: Multicenter retrospective cohorts.

Chamadol N, Laopaiboon V, Jareanrat A, Thanasukarn V, Srisuk T, Luvira V Heliyon. 2024; 10(18):e38191.

PMID: 39381227 PMC: 11458967. DOI: 10.1016/j.heliyon.2024.e38191.

Re- Infection Rate of Opisthorchis Viverrini Five Years After Treatment with Praziquantel in High-Risk Area: A Community-Based Study.

Saengsawang P, Buakate P Asian Pac J Cancer Prev. 2024; 25(8):2679-2684.

PMID: 39205565 PMC: 11495455. DOI: 10.31557/APJCP.2024.25.8.2679.

Development of a subunit vaccine against the cholangiocarcinoma causing : a computational approach.

Shah M, Sitara F, Sarfraz A, Shehroz M, Wara T, Perveen A Front Immunol. 2024; 15:1281544.

PMID: 39050853 PMC: 11266093. DOI: 10.3389/fimmu.2024.1281544.

An Extendible Realism-Based Ontology for Kinship.

Rabenberg M, Pengput A, Ceusters W CEUR Workshop Proc. 2024; 3603:25-35.

PMID: 38808327 PMC: 11131162.

The Parasitism and Tumors Carcinogenesis: A Review Subject.

Alshewered A Acta Parasitol. 2024; 69(1):183-189.

PMID: 38489011 DOI: 10.1007/s11686-024-00832-z.

References

Nakeeb A, Lipsett P, Lillemoe K, Coleman J, Cameron J, Pitt H . Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. Am J Surg. 1996; 171(1):147-52; discussion 152-3. DOI: 10.1016/S0002-9610(99)80090-7. View

Ross J, Schenkein D, Pietrusko R, Rolfe M, Linette G, Stec J . Targeted therapies for cancer 2004. Am J Clin Pathol. 2004; 122(4):598-609. DOI: 10.1309/5CWP-U41A-FR1V-YM3F. View

Sriputtha S, Khuntikeo N, Promthet S, Kamsa-Ard S . Survival rate of intrahepatic cholangiocarcinoma patients after surgical treatment in Thailand. Asian Pac J Cancer Prev. 2013; 14(2):1107-10. DOI: 10.7314/apjcp.2013.14.2.1107. View

Elkins D, Haswell-Elkins M, Mairiang E, Mairiang P, Sithithaworn P, Kaewkes S . A high frequency of hepatobiliary disease and suspected cholangiocarcinoma associated with heavy Opisthorchis viverrini infection in a small community in north-east Thailand. Trans R Soc Trop Med Hyg. 1990; 84(5):715-9. DOI: 10.1016/0035-9203(90)90159-c. View

Sripa B, Pairojkul C . Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol. 2008; 24(3):349-56. PMC: 4130346. DOI: 10.1097/MOG.0b013e3282fbf9b3. View

Cheng Q, Yi B, Wang J, Jiang X, Luo X, Liu C . Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV. Eur J Surg Oncol. 2012; 38(12):1197-203. DOI: 10.1016/j.ejso.2012.08.009. View

Ramage J, Donaghy A, Farrant J, Iorns R, Williams R . Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology. 1995; 108(3):865-9. DOI: 10.1016/0016-5085(95)90462-x. View

Khuntikeo N, Pugkhem A, Titapun A, Bhudhisawasdi V . Surgical management of perihilar cholangiocarcinoma: a Khon Kaen experience. J Hepatobiliary Pancreat Sci. 2014; 21(8):521-4. DOI: 10.1002/jhbp.74. View

Boonyanugomol W, Chomvarin C, Sripa B, Bhudhisawasdi V, Khuntikeo N, Hahnvajanawong C . Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation. HPB (Oxford). 2012; 14(3):177-84. PMC: 3371200. DOI: 10.1111/j.1477-2574.2011.00423.x. View

10.

Khampitak T, Knowles J, Yongvanit P, Sithithaworn P, Tangrassameeprasert R, Boonsiri P . Thiamine deficiency and parasitic infection in rural Thai children. Southeast Asian J Trop Med Public Health. 2006; 37(3):441-5. View

11.

Patel A, Harnois D, Klee G, Larusso N, Gores G . The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol. 2000; 95(1):204-7. DOI: 10.1111/j.1572-0241.2000.01685.x. View

12.

Sithithaworn P, Yongvanit P, Duenngai K, Kiatsopit N, Pairojkul C . Roles of liver fluke infection as risk factor for cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2014; 21(5):301-8. DOI: 10.1002/jhbp.62. View

13.

Jongsuksuntigul P, Imsomboon T . Opisthorchiasis control in Thailand. Acta Trop. 2003; 88(3):229-32. DOI: 10.1016/j.actatropica.2003.01.002. View

14.

Krause D, Van Etten R . Tyrosine kinases as targets for cancer therapy. N Engl J Med. 2005; 353(2):172-87. DOI: 10.1056/NEJMra044389. View

15.

Hanahan D, Weinberg R . The hallmarks of cancer. Cell. 2000; 100(1):57-70. DOI: 10.1016/s0092-8674(00)81683-9. View

16.

Brockelman W, Upatham E, Viyanant V, Hirunraks A . Measurement of incidence of the human liver fluke, Opisthorchis viverrini, in northeast Thailand. Trans R Soc Trop Med Hyg. 1987; 81(2):327-35. DOI: 10.1016/0035-9203(87)90255-0. View

17.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

18.

Worasith C, Kamamia C, Yakovleva A, Duenngai K, Wangboon C, Sithithaworn J . Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine. PLoS Negl Trop Dis. 2015; 9(10):e0004157. PMC: 4618926. DOI: 10.1371/journal.pntd.0004157. View

19.

Razumilava N, Gores G . Cholangiocarcinoma. Lancet. 2014; 383(9935):2168-79. PMC: 4069226. DOI: 10.1016/S0140-6736(13)61903-0. View

20.

Yongvanit P, Pinlaor S, Loilome W . Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2014; 21(5):309-15. DOI: 10.1002/jhbp.63. View